Market Tracker

03/27 6:01pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

22.70
Delayed Data
As of Mar 27
 +0.33 / +1.48%
Today’s Change
12.50
Today|||52-Week Range
26.89
+34.64%
Year-to-Date

Today’s Trading

Previous close22.37
Today’s open22.49
Day’s range22.41 - 23.24
Volume506,258
Average volume (3 months)420,240
Market cap$656.4M
Dividend yield--
Data as of 4:00pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)-3.20%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...+0.50+3.57%
AMPHAmphastar Pharmaceut...+0.48+3.21%
FLMLFlamel Technologies ...+0.05+0.28%
VTLVital Therapies Inc-0.51-1.96%
Data as of 4:14pm ET, 03/27/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts